Journals / Kafkas Üniversitesi Veteriner Fakültesi Dergisi / 2022 / Cilt: 28 - Sayı: 1

Effect of Tocilizumab on Acinetobacter baumannii Lung Infection in an Immunosuppressed Rat Model

Tocilizumab’ın İmmünsüprese Rat Modelinde Acinetobacter baumannii’nin Akciğer Enfeksiyonu Üzerindeki Etkisi

Pages
87–96
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

NF-κB, IL-6 and NLRP3 mRNA expressions were decreased in the IM group compared to the healthy group (P

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Our study aimed to investigate effect of tocilizumab on the lung tissue in the presence of Acinetobacter baumannii infection in immunosuppressed rats.
📊
Key Findings & Data:A forty-eight female Wistar albino rats were divided equally into eight groups: Group 1: Healthy (H), Group 2: Immunosuppressed (IM), Group 3: Healthy rats given A. baumannii bacteria (H+BAC), Group 4: Immunosuppressed rats given A. baumannii bacteria (IM+BAC), Group 5: Healthy rats given tocilizumab (H+TCZ), Group 6: Immunosuppressed rats given tocilizumab (IM+TCZ), Group 7: Healthy rats given A. baumannii bacteria and tocilizumab (H+BAC+TCZ), Group 8: Immunosuppressed rats given tocilizumab and A. baumannii bacteria (IM+BAC+TCZ).
💡
Conclusion & Impact:NF-κB, IL-6 and NLRP3 mRNA expressions were decreased in the IM group compared to the healthy group (P
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Our study aimed to investigate effect of tocilizumab on the lung tissue in the presence of Acinetobacter baumannii infection in immunosuppressed rats. A forty-eight female Wistar albino rats were divided equally into eight groups: Group 1: Healthy (H), Group 2: Immunosuppressed (IM), Group 3: Healthy rats given A. baumannii bacteria (H+BAC), Group 4: Immunosuppressed rats given A. baumannii bacteria (IM+BAC), Group 5: Healthy rats given tocilizumab (H+TCZ), Group 6: Immunosuppressed rats given tocilizumab (IM+TCZ), Group 7: Healthy rats given A. baumannii bacteria and tocilizumab (H+BAC+TCZ), Group 8: Immunosuppressed rats given tocilizumab and A. baumannii bacteria (IM+BAC+TCZ). Fourteen days after the immunosuppression of group 2, 4, 6 and 8 with hydrocortisone, group 3, 4, 7 and 8 were A. baumannii was dropped into the trachea. One hour after A. baumannii application, TCZ was administered to Groups 5, 6, 7 and 8. NF-κB, IL-6 and NLRP3 mRNA expressions were decreased in the IM group compared to the healthy group (P

Özet

Çalışmamızda, immünsüpresyon oluşturulmuş ratlarda Acinetobacter baumannii enfeksiyonu varlığında tocilizumabın akciğer dokusundaki etkisini araştırmayı amaçladık. Toplam kırk sekiz dişi Wistar albino rat sekiz eşit gruba ayrıldı: Grup 1: Sağlıklı (H), Grup 2: İmmünsüprese ratlar (IM), Grup 3: A. baumannii bakterisi verilen sağlıklı ratlar (H+BAC), Grup 4: A. baumannii bakterisi verilen immünsüprese ratlar, Grup 5: Tocilizumab verilen sağlıklı ratlar (H+TCZ), Grup 6: Tocilizumab verilen immünsüprese ratlar (IM+TCZ), Grup 7: A. baumannii bakterisi ve tocilizumab verilen sağlıklı ratlar (H+BAC+TCZ), Grup8: Tocilizumab ve A. baumannii bakterisi verilen immünsüprese sıçanlar (IM+BAC+TCZ). Grup 2, 4, 6 ve 8’in hidrokortizon ile immünosupresyonundan 14 gün sonra, grup 3, 4, 7 ve 8’e A. baumannii suşu trakeaya transtrakeal yolla enjekte edildi. Grup 5, 6, 7 ve 8’e A. baumannii uygulamasından bir saat sonra TCZ verildi. İmmünsüprese grupta (IM) sağlıklı gruba (H) göre NF-κB, IL-6 ve NLRP3 mRNA ekspresyonları azaldı (P

🔖

Cite This Article

HALICI, Z., KESKIN, H., CELEBI, D., YILDIRIM, S., CELEBI, O., AKGUN, N., CINAR, I., HALICI, I., CINISLI, K. T. (2022). Effect of Tocilizumab on Acinetobacter baumannii Lung Infection in an Immunosuppressed Rat Model. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 28 - Sayı: 1, 87–96. https://ajindex.com/articles/569455

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Baumann P, Doudoroff M, Stanier RY: A study of the Moraxella group II. Oxidative-negative species (genus Acinetobacter). J Bacteriol, 95 (5): 1520-1541, 1968. DOI: 10.1128/jb.95.5.1520-1541.1968 2. Bouvet PJM, Grimont PAD: Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov. and emended descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int J Syst Evol, 36 (2): 228-240, 1986. DOI: 10.1099/00207713-36-2-228 3. Dijkshoorn L, Nemec A, Seifert H: An increasing threat in hospitals: Multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol, 5 (12): 939-951, 2007. DOI: 10.1038/nrmicro1789 4. Munoz-Price LS, Weinstein RA: Acinetobacter infection. N Engl J Med, 358 (12): 1271-1281, 2008. DOI: 10.1056/NEJMra070741 5. Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B, Spellberg B: Clinical and pathophysiological overview of Acinetobacter infections: A century of challenges. Clin Microbiol Rev, 30 (1): 409-447, 2017. DOI: 10.1128/CMR.00058-16 6. Chung DR, Song JH, Kim SH, Thamlikitkul V, Huang SG, Wang H, So TMK, Yasin RMD, Hsueh PR, Carlos CC, Hsu LY, Buntaran L, Lalitha MK, Kim MJ, Choi LY, Kim SII, Ko KS, Kang CI, Peck KR, Asian Network for Surveillance of Resistant Pathogens Study Group: High prevalence of multidrug-resistant nonfermenters in hospital-acquired pneumonia in Asia. Am J Respir Crit Care Med, 184 (12): 1409-1417, 2011. DOI: 10.1164/ rccm.201102-0349OC 7. Tognim MCB, Andrade SS, Silbert S, Gales AC, Jones RN, Sader HS: Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: Five-year report of the SENTRY Antimicrobial Surveillance Program. Int J Infect Dis, 8 (5): 284-291, 2004. DOI: 10.1016/j.ijid.2003.11.009 8. Van Dessel H, Dijkshoorn L, van der Reijden T, Bakker N, Paauw A, van den Broek P, Verhoef J, Brisse S: Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol, 155 (2): 105-112, 2004. DOI: 10.1016/ j.resmic.2003.10.003 9. Gaddy JA, Arivett BA, McConnell MJ, López-Rojas R, Pachón J, Actis LA: Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infect Immun, 80